🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 12% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
Fat/Fatty Acid Product Type
12% Evidence Coverage

Supplement Facts — Evidence Check

Calories
10 {Calories}
Calories from Fat
10 {Calories}
Total Fat
1 g (2% DV)
Sodium
Total Carbohydrates
Protein
2 IU (7% DV)
✅ Within RDA (0.1× RDA of 15 mg) 📚 177 studies (Tier A: 3, B: 90)
RDA 15mg This product: 1.34mg UL 1000mg
Marine Lipid concentrate
1000 mg

Other Ingredients

Gelatin Glycerin Water

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Suggested Usage: As a dietary supplement, adults take one (1) capsule two (2) times daily with meals, or as directed by a health care professional.

⚠️ Warnings & Precautions

Keep out of reach of children.

🧪 Formulation Notes

Contains No Added sugar, salt, dairy, yeast, corn, preservatives, artificial colors or flavors.

Additional Information

Store in a cool, dry place and away from direct light.

This supplement is extracted from fish body oils at low temperature without the use of harsh solvents. DH and EPA are important omega-3 fatty acids.

QUALITY AND POTENCY GUARANTEED

"We Make It Better..."

#10104

Natural Source of Omega-3 Fatty Acids

Not a significant source of dietary fiber, sugars, vitamin A, vitamin C, calcium and iron.

Product Details

DSLD Entry Date 2013-03-25
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 19583
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →